Market Cap N/A
Revenue (ttm) 18.51M
Net Income (ttm) -59.04M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 460
Avg Vol 4,358
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 73%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers. It offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde...

Industry: Medical Devices
Sector: Healthcare
Phone: (888) 321-5212
Address:
6272 West 91st Avenue, Westminster, United States
Latest News on TLSIW
No data available.